Category Cancer Types

8
Jun

Melanoma Awereness Night At The Philles Organized By Kelly Kroll and the “Bonnie Kroll Melanoma Memorial Fund”

May is Melanoma Awareness Month. Kelly Kroll of Ambler PA has set up the “Bonnie Kroll Melanoma Memorial Fund” in honor of her mother who died in 2001 from uveal melanoma. The fund has raised over $150,000 to support research at the the Thomas Jefferson University Hospital and the Kimmel Cancer Center of Thomas Jefferson …

1
Jun

Dr. Karen Knudsen Receives Ron Ross Award

See the Award Announcement for more information about the Award and its latest recipient. The following was abstracted from the announcement. Dr. Karen Knudsen of the Kimmel Cancer Center received the Ron Ross Award at the 5th Pacific Rim Breast and Prostate Cancer Meeting, held in Kingscliff, Australia, May 3-7, 2011. Dr. Ron Ross was …

1
Jun

KCC Research: Cancer Cells Accelerate Aging & Inflammation in Body to Drive Tumor Growth

Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow—and how to make it stop.  Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides “fuel” for the tumor to grow and even metastasize. This revealing …

23
May

Highlights from KCC American Cancer Society Research Symposium

The Kimmel Cancer Center at Jefferson hosted the 3rd Annual American Cancer Society Research Symposium: Celebrating the ACS Institutional Research Grant at KCC on May 6, 2011. Dr. Nevalainen welcomed members of the KCC and TJU community and the American Cancer Society. Richard Pestell, MD, PhD gave the Keynote Address, “Cancer Invasion and Metastasis and …

19
May

Marker Identifies Breast Cancer Patients Likely to Respond to Tamoxifen

ER positive breast cancer patients whose tumors have active protein Stat5 have increased likelihood of responding to anti-estrogen therapy PHILADELPHIA—Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy. The research appears …

17
May

Dr. Sato Recieves Generous Gift For Uveal Melanoma Research

Benefactors Mark and Alison Weinzierl pose with Kimmel Cancer Center Director Dr. Richard G. Pestell (R) and Dr. Takami Sato (L), Professor of Medical Oncology and director of the Uveal Melanoma research program at the KCC.  The Weinzierls (from the Dallas, Texas, area) are providing $1 million in support of Dr. Sato’s work.

6
May

KCC American Cancer Society Research Symposium

The 3rd Annual Kimmel Cancer Center American Cancer Society Research Symposium will be held today at 2 p.m. in 101 BLSB. KCC Director Richard Pestell, M.D, Ph.D, will present the keynote address and 2010 American Cancer Society-Institutional Research Grant Award recipients. Amy Leader, DrPH, MPH, and Hushan Yang, Ph.D, will discuss their research. A reception …

26
Apr

KCC Team to Walk for Bladder Cancer

It is estimated that more than 70,000 new cases of bladder cancer were diagnosed in 2010, making it the 5th most commonly diagnosed cancer in the U.S. Please join Dr. Jean Hoffman-Censits, of the Department of Medical Oncology, Solid Tumor Division, and the Kimmel Cancer Center at Jefferson Team in raising awareness of the disease …

19
Apr

Dr. Edith Mitchell attends National Summit on Health Disparities, Hon. Nancy Pelosi and Sen. Harry Reid honored

Edith Mitchell, M.D., clinical professor of Medicine and Medical Oncology at Jefferson Medical College of Thomas Jefferson University, attended the 8th Annual National Summit on Health Disparities Meeting & Awards Dinner in Washington, D.C., on April 11 and 12. The summit, organized by The National Minority Quality Forum and the Congressional Black Caucus Foundation, in …

19
Apr

Jefferson Researchers Unlock Key to Personalized Cancer Medicine Using Tumor Metabolism

Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any …

13
Apr

Jefferson Doctors Strengthen Case for High-Dose Radiotherapy Technique After Radical Prostatectomy

A widely-available yet expensive radiotherapy technique used to treat prostate cancer patients after surgery has promising benefits—higher dose and less damage to the rectum and bladder—compared to a less precise technique, Thomas Jefferson University researchers document for the first time in a new study published in Practical Radiation Oncology. A team of radiation oncologists and …

7
Apr

Celebrating National Cancer Registrars Week

Cancer Registrars throughout the United States and abroad will join their colleagues, community leaders, and other medical professionals to observe the 15th annual National Cancer Registrars Week, April 11th-15th. Quality cancer data is central to the nation’s fight against cancer, and cancer registrars are the first link in capturing these data. Our Cancer Registry works …

6
Apr

Kimmel Cancer Center at Jefferson breast cancer symposium features latest in research, treatment

The latest advances in both breast cancer treatment and research – including innovations in diagnostic, surgical, chemotherapy and radiation approaches – will be discussed Friday, April 8, 2011, at a breast cancer symposium at the Kimmel Cancer Center at Jefferson in Philadelphia. The all-day, breast cancer symposium, part of an annual series at the Kimmel …

22
Mar

Jefferson Clinical Trial: Can a Cholesterol Drug Prevent Colon Cancer?

Thomas Jefferson University has started recruiting patients for a new National Cancer Institute (NCI)-sponsored clinical trial to test whether the cholesterol-reducing drug rosuvastatin is effective in the prevention of recurrent colon cancer. Previous laboratory research and population studies have shown that patients taking statins, the class of drugs that lowers cholesterol, had fewer colon polyps, …

10
Mar

Jefferson Researchers Unravel Protein’s Elusive Role in Embryo and Disease Development in Nature

Reporting in Nature, scientists from Thomas Jefferson University have determined that a single protein called FADD controls multiple cell death pathways, a discovery that could lead to better, more targeted autoimmune disease and cancer drugs. Twelve years ago, internationally-known immunologistan associate professor in the Department of Microbiology and Immunology at Thomas Jefferson University, realized FADD, …

1
Mar

Radiation Oncology Announcements and Appointments

New faculty: Thomas Jefferson University welcomes two new, seasoned clinicians and researchers to its Department of Radiation Oncology: Nicole Simone, M.D., from the National Institutes of Health’s National Cancer Institute (NCI) and Bo Lu, M.D., Ph.D, from Vanderbilt University. Dr. Simone is a board-certified Radiation Oncologist who has treated mostly patients with breast and head …

22
Feb

“Longevity” Protein SIRT1 May Ward Off Precursor to Prostate Cancer

Researchers from the Kimmel Cancer Center at Jefferson and two other institutions have discovered new evidence that suggests the “longevity” protein SIRT1, known for its life-spanning effects in different species, can inhibit the development of a known precursor to prostate cancer, prostatic intraepithelial neoplasia (PIN). “Prostate cancer is one of the malignancies that has a …

21
Feb

Dr. Leonard Gomella co-chairs ASCO GU in Orlando

Dr. Leonard G. Gomella, chair of the Department of Urology and director of Clinical Affairs at the Kimmel Cancer Center at Jefferson, co-chaired the American Society of Clinical Oncology (ASCO) 2011 Genitourinary (GU) Cancers Symposium meeting in Orlando on Feb. 17 though Feb. 19. The “2011 Genitourinary Cancers Symposium: An Evidence-based Multidisciplinary Approach,” was a …

16
Feb

Shifting a paradigm: A molecular approach to staging colorectal cancer

A quantitative, molecular analysis of lymph nodes in patients deemed colorectal cancer-free was found to be an effective predictor of recurrence, according to a study from researchers at the Kimmel Cancer Center at Jefferson and published online Feb 9. in Clinical Cancer Research. Recurrence occurs in about 25 percent of node-negative patients (pN0), suggesting that …

15
Feb

Researchers Say Stress Fuels Cancer Growth, Provide Genetic Evidence That Antioxidants Can Help Treat It

Researchers from Jefferson’s Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress—a culprit in driving tumor growth. For the first time, the researchers show that loss of the …

Page 8 of 11